New Competitor to Wegovy Shows Promise in Clinical Trials
TUESDAY, June 27, 2023 (HealthDay News) — An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows. Retatrutide helped people with obesity drop about one-quarter of their starting weight, on average, during 48 weeksContinue Reading